Structure-activity relationships for 1-alkyl-3-(l-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors:: steric and electronic effects of naphthoyl substituents.: New highly selective CB2 receptor agonists

被引:220
|
作者
Huffman, JW [1 ]
Zengin, G
Wu, MJ
Lu, JZ
Hynd, G
Bushell, K
Thompson, ALS
Bushell, S
Tartal, C
Hurst, DP
Reggio, PH
Selley, DE
Cassidy, MP
Wiley, JL
Martin, BR
机构
[1] Clemson Univ, Howard L Hunter Lab, Clemson, SC 29634 USA
[2] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
cannabinoids; structure-activity relationships; cannabinoid receptors; aminoalkylindole;
D O I
10.1016/j.bmc.2004.09.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In an effort to improve indole-based CB2 cannabinoid receptor ligands and also to develop SAR for both the CB1 and CB2 receptors, 47 indole derivatives were prepared and their CB1 and CB2 receptor affinities were determined. The indole derivatives include 1-propyl- and 1-pentyl-3-(1-naphthoyl)indoles both with and without a 2-methyl substituent. Naphthoyl substituents include 4- and 7-alkyl groups as well as 2-, 4-, 6-, 7-methoxy and 4-ethoxy groups. The effects of these substituents on receptor affinities are discussed and structure-activity relationships are presented. In the course of this work three new highly selective CB2 receptor agonists were identified, 1-propyl-3-(4-methyl-1-naphthoylindole (JWH-120), 1-propyl-2-methyl-3-(6-methoxy-1-naphthoylindole (JWH-151), and 1-pentyl-3-(2-methoxy-1-naphthoylindole (JWH-267). GTPgammaS assays indicated that JWH-151 is a full agonist at CB2, while JWH-120 and JWH-267 are partial agonists. Molecular modeling and receptor docking studies were carried out on a set of 3-(4-propyl-1-naphthoyl)indoles, a set of 3-(6-methoxy-1-naphthoyl)indoles and the pair of N-pentyl-3-(2-methoxy-1-naphthoyl)indoles. Docking studies indicated that the CB1 receptor affinities of these compounds were consistent with their aromatic stacking interactions in the aromatic microdomain of the CB1 receptor. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:89 / 112
页数:24
相关论文
共 50 条
  • [31] Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine:: Role of CB1 and CB2 receptors
    Ugdyzhekova, DS
    Bernatskaya, NA
    Stefano, JB
    Graier, VF
    Tam, SW
    Mekhoulam, R
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (03) : 251 - 253
  • [32] Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice
    Poleszak, Ewa
    Wosko, Sylwia
    Slawinska, Karolina
    Wyska, Elzbieta
    Szopa, Aleksandra
    Swiader, Katarzyna
    Wrobel, Andrzej
    Doboszewska, Urszula
    Wlaz, Piotr
    Wlaz, Aleksandra
    Serefko, Anna
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2020, 188
  • [33] 3D-QSAR/CoMFA-Based Structure-Affinity/Selectivity Relationships of Aminoalkylindoles in the Cannabinoid CB1 and CB2 Receptors
    Mella-Raipan, Jaime
    Hernandez-Pino, Santiago
    Morales-Verdejo, Cesar
    Pessoa-Mahana, David
    MOLECULES, 2014, 19 (03) : 2842 - 2861
  • [34] Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
    Polini, Beatrice
    Cervetto, Chiara
    Carpi, Sara
    Pelassa, Simone
    Gado, Francesca
    Ferrisi, Rebecca
    Bertini, Simone
    Nieri, Paola
    Marcoli, Manuela
    Manera, Clementina
    LIFE-BASEL, 2020, 10 (12): : 1 - 14
  • [35] Consequence of dopamine D2 receptor blockade on the hyperphagic effect induced by cannabinoid CB1 and CB2 receptors in layers
    Khodadadi, M.
    Zendehdel, M.
    Baghbanzadeh, A.
    Babapour, V.
    BRITISH POULTRY SCIENCE, 2017, 58 (05) : 585 - 593
  • [36] The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats
    Adamczyk, Przemyslaw
    Miszkiel, Joanna
    McCreary, Andrew C.
    Filip, Malgorzata
    Papp, Mariusz
    Przegalinski, Edmund
    BRAIN RESEARCH, 2012, 1444 : 45 - 54
  • [37] Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia
    Scherma, Maria
    Satta, Valentina
    Collu, Roberto
    Boi, Maria Francesca
    Usai, Paolo
    Fratta, Walter
    Fadda, Paola
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (16) : 2682 - 2695
  • [38] Ligand-ligand and ligand-receptor approaches to modeling the cannabinoid CB1 and CB2 receptors:: Achievements and challenges
    Reggio, PH
    CURRENT MEDICINAL CHEMISTRY, 1999, 6 (08) : 665 - 683
  • [39] Relative involvement of cannabinoid CB1 and CB2 receptors in the Δ9-tetrahydrocannabinol-induced inhibition of natural killer activity
    Massi, P
    Fuzio, D
    Viganò, D
    Sacerdote, P
    Parolaro, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (03) : 343 - 347
  • [40] The effects of charge-neutralizing mutation D6.30N on the functions of CB1 and CB2 cannabinoid receptors
    Nebane, Ntsang M.
    Kellie, Brandon
    Song, Zhao-Hui
    FEBS LETTERS, 2006, 580 (22) : 5392 - 5398